172 related articles for article (PubMed ID: 16467330)
1. Human interleukin-15 improves engraftment of human T cells in NOD-SCID mice.
Sun A; Wei H; Sun R; Xiao W; Yang Y; Tian Z
Clin Vaccine Immunol; 2006 Feb; 13(2):227-34. PubMed ID: 16467330
[TBL] [Abstract][Full Text] [Related]
2. Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency.
Murphy WJ; Conlon KC; Sayers TJ; Wiltrout RH; Back TC; Ortaldo JR; Longo DL
J Immunol; 1993 Apr; 150(8 Pt 1):3634-42. PubMed ID: 8468492
[TBL] [Abstract][Full Text] [Related]
3. Human prolactin improves engraftment and reconstitution of human peripheral blood lymphocytes in SCID mice.
Sun R; Zhang J; Zhang C; Zhang J; Liang S; Sun A; Wang J; Tian Z
Cell Mol Immunol; 2004 Apr; 1(2):129-36. PubMed ID: 16212900
[TBL] [Abstract][Full Text] [Related]
4. In vivo engraftment potential of clinical hematopoietic grafts.
Leung W; Ramírez M; Novelli EM; Civin CI
J Investig Med; 1998 Aug; 46(6):303-11. PubMed ID: 9737093
[TBL] [Abstract][Full Text] [Related]
5. Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice.
Camacho RE; Wnek R; Shah K; Zaller DM; O'Reilly RJ; Collins N; Fitzgerald-Bocarsly P; Koo GC
Cell Immunol; 2004; 232(1-2):86-95. PubMed ID: 15922719
[TBL] [Abstract][Full Text] [Related]
6. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.
Shultz LD; Schweitzer PA; Christianson SW; Gott B; Schweitzer IB; Tennent B; McKenna S; Mobraaten L; Rajan TV; Greiner DL
J Immunol; 1995 Jan; 154(1):180-91. PubMed ID: 7995938
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development.
Camacho RE; Wnek R; Fischer P; Shah K; Zaller DM; Woods A; La Monica N; Aurisicchio L; Fitzgerald-Bocarsly P; Koo GC
Exp Hematol; 2007 Aug; 35(8):1219-30. PubMed ID: 17662890
[TBL] [Abstract][Full Text] [Related]
8. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
[TBL] [Abstract][Full Text] [Related]
9. Antitumor immune response of human peripheral blood lymphocytes coengrafted with tumor into severe combined immunodeficient mice.
Iwanuma Y; Chen FA; Egilmez NK; Takita H; Bankert RB
Cancer Res; 1997 Jul; 57(14):2937-42. PubMed ID: 9230205
[TBL] [Abstract][Full Text] [Related]
10. Human recombinant interleukin-4 (HurIL-4) improves SCID mouse reconstitution with human peripheral blood lymphocytes.
Bombil F; Latinne D; Kints JP; Bazin H
Immunobiology; 1996; 196(4):437-48. PubMed ID: 9061383
[TBL] [Abstract][Full Text] [Related]
11. [Human peripheral blood CD4+ T-lymphocytes reconstituting severe combined immunodeficient mouse-human cell immune system and its immunological function].
Zeng QH; Wang W; Liu T; Shi Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):513-6. PubMed ID: 16137035
[TBL] [Abstract][Full Text] [Related]
12. [Establishment of an xenogeneic acute graft-versus-host disease model in NOD/SCID mice by engraftment of G-CSF mobilized human mononuclear cells].
Gao L; Wang JM; Xie LN; Zhou H; Qiu HY
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):87-91. PubMed ID: 18681307
[TBL] [Abstract][Full Text] [Related]
13. Engraftment of human T, B and NK cells in CB.17 SCID/beige mice by transfer of human spleen cells.
Yacoub-Youssef H; Marcheix B; Calise D; Thiers JC; Therville N; Benoist H; Blaes N; Ségui B; Dambrin C; Thomsen M
Transpl Immunol; 2005 Dec; 15(2):157-64. PubMed ID: 16412960
[TBL] [Abstract][Full Text] [Related]
14. Compartmentalization of allogeneic T-cell responses in the bone marrow and spleen of humanized NOD/SCID mice containing activated human resident myeloid dendritic cells.
Vuckovic S; Abdul Wahid FS; Rice A; Kato M; Khalil D; Rodwell R; Hart DN
Exp Hematol; 2008 Nov; 36(11):1496-506. PubMed ID: 18715688
[TBL] [Abstract][Full Text] [Related]
15. Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice.
Murphy WJ; Durum SK; Longo DL
Proc Natl Acad Sci U S A; 1992 May; 89(10):4481-5. PubMed ID: 1584780
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts.
Murphy WJ; Back TC; Conlon KC; Komschlies KL; Ortaldo JR; Sayers TJ; Wiltrout RH; Longo DL
J Clin Invest; 1993 Oct; 92(4):1918-24. PubMed ID: 8408644
[TBL] [Abstract][Full Text] [Related]
18. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
19. SCID mouse as a model for transplantation studies.
Renz JF; Lin Z; de Roos M; Dalal AA; Ascher NL
J Surg Res; 1996 Sep; 65(1):34-41. PubMed ID: 8895604
[TBL] [Abstract][Full Text] [Related]
20. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
